Published

Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: Psychiatry Research
Date: 2026-02-12
Source: OpenAlex
DOI: 10.1016/j.psychres.2026.117010
PubMed: 41747432

Authors

Sean P. Goldy Nathan D. Sepeda Samantha Hilbert Bilal A. Bari Albert Garcia-Romeu Natalie Gukasyan Frederick S. Barrett David B. Yaden Sandeep M. Nayak

Watch author

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones2026-02-12

Related papers

Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic PotentialDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21 Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal IdeationThe Journal of Clinical Psychiatry · 2026-05-11 Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidencePsychedelics. · 2025-10-27 The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysisBMC Psychology · 2026-01-01 Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?Medical Sciences · 2025-11-19 Pilot study of psilocybin in patients with post-treatment lyme diseaseScientific Reports · 2026-02-24 Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?Clinical Pharmacology & Therapeutics · 2023-10-04 The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.ClinicalTrials.gov · 2026-05-07